By modulating the activity of methyltransferases such as METTL1 or WDR4, the level of m7G modification can be altered, thereby regulating the expression of related genes and cellular functions, and offering new hope for the treatment of digestive diseases. Here, WDR4 is linked to digestive system disorder.